Eric M. Attias
InvestorManaging Partner, Bio&Med Fund; Co-Managing Partner, Brain AI Fund; Founder at Forepont Capital Partners
New York
About
Eric M. Attias founded Forepont in 2017 and serves as managing partner of its Bio&Med Fund and co-managing partner of its Brain AI Fund. He has an investment and company-building background that includes early investments in Synchron and Precision Neuroscience, as well as building, acquiring, and selling companies such as Nexar (sold to UBP) and stakes tied to Allianz's AAAM and Ermitage. He previously managed a large alternative investment company and holds degrees in computer science (neural networks), engineering, and business administration.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Experience
- Forepont Capital PartnersFoundercurrent2017 — presentNew York, United States
- UBP - Union Bancaire PrivéeNEXAR | Founder | Sold to bank UBP|2009 — 2015New York, United States
- AllianzNEXAR acquires Allianz Alternative Group (AAAM) from Allianz2010
- Caledonia Private CapitalNEXAR acquires Ermitage from Caledonia2010
- Nexar GroupNEXAR | Co-Founder | Chief Executive LLC | Chief Investment | Acquired by UBP |2009New York, London, Jersey, Luxembourg, Paris
- Societe GeneraleSG Asset Management Inc | Founder | Chief Executive | Chief Investment |2002 — 2009United States
- Dresdner Kleinwort WassersteinInvestment Bank Board - ExCo | Department Head | Emerging Markets |1997 — 2002New York | London | Frankfort |
- Bankers TrustEM senior Trader1996 — 1997London Area, United Kingdom
Investments
Investor
Precision NeuroscienceSynchron
Per the firm's website.
Colleagues at Forepont Capital Partners
Frequently asked questions
- Who is Eric M. Attias?
- Eric M. Attias founded Forepont in 2017 and serves as managing partner of its Bio&Med Fund and co-managing partner of its Brain AI Fund. He has an investment and company-building background that includes early investments in Synchron and Precision Neuroscience, as well as building, acquiring, and selling companies such as Nexar (sold to UBP) and stakes tied to Allianz's AAAM and Ermitage. He previously managed a large alternative investment company and holds degrees in computer science (neural networks), engineering, and business administration.
- Where does Eric M. Attias work?
- Eric M. Attias is Managing Partner, Bio&Med Fund; Co-Managing Partner, Brain AI Fund; Founder at Forepont Capital Partners.
- What does Eric M. Attias invest in?
- Eric M. Attias invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- What companies has Eric M. Attias invested in?
- Investments tracked here include Precision Neuroscience, Synchron.
- Where did Eric M. Attias go to school?
- Eric M. Attias studied at Columbia University (Master of Business Administration); London Business School (PE & VC Executive Program); Massachusetts Institute of Technology (PhD (ABD)).
Same school
Also attended Columbia University894
+ 888 more
Also attended Massachusetts Institute of Technology1,535
+ 1,529 more
Also attended Université Paris Dauphine - PSL252
+ 246 more
Also attended ENSAE Paris22
+ 16 more
Shared employers
Also worked at UBP - Union Bancaire Privée13
+ 7 more
Also worked at Allianz63
+ 57 more














































